UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | F | G | H | K | L | M | N | O | P | R | S | T | V | W
Number of items: 63.

A

Alliouachene, S; Tuttle, RL; Boumard, S; Lapointe, T; Berissi, S; Germain, S; Jaubert, F; ... Pende, M; + view all (2008) Constitutively active Akt1 expression in mouse pancreas requires S6 kinase 1 for insulinoma formation. J Clin Invest , 118 (11) pp. 3629-3638. 10.1172/JCI35237.

Alonso, S; Lopez, S; Izagirre, N; de la Rua, C; (2008) Overdominance in the Human Genome and Olfactory Receptor Activity. Molecular Biology and Evolution , 25 (5) pp. 997-1001. 10.1093/molbev/msn049.

Alonzi, R.; (2008) Evaluation of the oxygenation and vascularity of prostate cancer using magnetic resonance imaging. Doctoral thesis , University of London. Green open access
file

Arkenau, H; Barrius, J; Olmos, D; Ang, JE; De Bono, J; Judson, I; Kaye, SB; (2008) Prospective validation of a prognostic score to improve patient selection for phase-1 trials. In: ANNALS OF ONCOLOGY. (pp. 145 - 145). OXFORD UNIV PRESS

Arkenau, HT; Carden, CP; de Bono, JS; (2008) Targeted agents in cancer therapy. Medicine , 36 (1) pp. 33-37. 10.1016/j.mpmed.2007.10.007.

Arkenau, HT; Porschen, R; (2008) The combination of oxaliplatin with either capecitabine or infusional 5-fluorouracil/leucovorin results in comparable outcome in patients with metastatic colorectal cancer. American Journal of Hematology/ Oncology , 7 (1) pp. 35-37.

B

Barriuso, J; Arkenau, HT; Olmos, D; Ang, J; Brunetto, A; Frentzas, S; Ayite, B; ... Kaye, S; + view all (2008) PROSPECTIVE VALIDATION OF A PROGNOSTIC SCORE FOR PATIENTS TREATED IN PHASE-I TRIALS. In: (Proceedings) 33rd Congress of the European-Society-for-Medical-Oncology (ESMO). (pp. p. 164). OXFORD UNIV PRESS

Besana, P; Patkar, V; Glasspool, D; Robertson, D; (2008) Distributed Workflows: The OpenKnowledge Experience. In: Meersman, R and Tari, Z and Herrero, P, (eds.) ON THE MOVE TO MEANINGFUL INTERNET SYSTEMS: OTM 2008 WORKSHOPS. (pp. 965 - 975). SPRINGER-VERLAG BERLIN

Bielack, S; Marina, N; Ferrari, S; Helman, LH; Smeland, S; Whelan, JS; Reaman, GH; (2008) Response to Meyers et al, Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival- a report from the Children's Oncology Group (letter0. Journal of Clinical Oncology , 4 pp. 633-638.

Booth, CM; Calvert, AH; Giaccone, G; Lobbezoo, MW; Eisenhauer, EA; Seymour, LK; Task Force Methodology Dev Innovat, ; (2008) Design and conduct of phase II studies of targeted anticancer therapy: Recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT). EUR J CANCER , 44 (1) 25 - 29. 10.1016/j.ejca.2007.07.031.

Brown, T; Mackay, H; Turlington, M; Sutterfield, A; Smith, T; Sielaff, A; Westrate, L; ... and Lee, M; + view all (2008) Modifying the N-Terminus of Polyamides: PyImPyIm has Improved Sequence Specificity over f-ImPyIm. Bioorganic and Medicinal Chemistry , 16 pp. 5266-5276.

C

Calvert, AH; Plummer, R; (2008) The development of phase I cancer trial methodologies: the use of pharmacokinetic and pharmacodynamic end points sets the scene for phase 0 cancer clinical trials. CLIN CANCER RES , 14 (12) 3664 - 3669. 10.1158/1078-0432.CCR-07-4559.

Cassoni, A; Ali, U; Cave, J; Edwards, SG; Ramsay, A; Miller, RF; Lee, SM; (2008) Remission After Radiotherapy for a Patient With Chemotherapy-Refractory HIV-Associated Primary Effusion Lymphoma. J CLIN ONCOL , 26 (32) 5297 - 5299. 10.1200/JCO.2008.18.3350.

Cassoni, A; Ali, U; Cave, J; Edwards, SG; Ramsay, A; Miller, RF; Siow, ML; (2008) Remission after radiotherapy for a patient with chemotherapy-refractory HIV-associated primary effusion lymphoma. Journal of Clinical Oncology , 26 (32) pp. 5297-5299. 10.1200/JCO.2008.18.3350.

D

Drew, Y; Calvert, H; (2008) The Potential of PARP Inhibitors in Genetic Breast and Ovarian Cancers. RECENT ADVANCES IN CLINICAL ONCOLOGY , 1138 136 - 145. 10.1196/annals.1414.020.

F

Fern, L; Campbell, C; Eden, T; Grant, R; lewis, I; McCleod, U; Weller, D; ... J, ; + view all (2008) Addressing delayed cancer diagnosis in primary care: Patterns of attendance and symptoms of teenagers and young adults seen in 3 general practices during 1 year. In:

Folarin, A.A.; (2008) Analysis of tumour angio-architecture and blood flow using microcomputed tomography and lattice Boltzmann simulations. Doctoral thesis , University of London. Green open access
file

Fox, J; Black, E; Chronakis, I; Dunlop, R; Patkar, V; South, M; Thomson, R; (2008) From guidelines to careflows: modelling and supporting complex clinical processes. Stud Health Technol Inform , 139 pp. 44-62.

G

Gaya, AM; Violet, J; Dancey, G; Green, A; Stratford, M; Sharma, S; Owen, K; ... Meyer, T; + view all (2008) A phase I/II trial of radioimmunotherapy with (131)Iodine labelled A5B7 anti-CEA antibody (I-131-A5B7) in combination with Combretastatin-A4-Phosphate (CA4P) in advanced gastrointestinal carcinomas. In: AMER SOC CLINICAL ONCOLOGY

Gelderblom, H; Sydes, MR; Morgan, RC; Hogendoorn, PC; Lewis, IJ; Nooij, MA; Taminiau, AH; (2008) Survival after recurrent osteosarcoma: Data from three European Osteosarcoma Intergroup (EOI) randomized controlled. Presented at: UNSPECIFIED.

Gillmore, R; Laurence, V; Paisey, S; Mukherjee, S; Hudson, E; Raouf, S; Collis, C; ... Bridgewater, J; + view all (2008) The role of chemoradiotherapy in sub-optimally resectable locally advanced adenocarcinoma of the pancreas. In: AMER SOC CLINICAL ONCOLOGY

Graham, JS; Plummer, R; McCoy, C; Kowal, K; Wiesinger, H; Detjen, K; Calvert, H; ... Cassidy, J; + view all (2008) Open-label, non-randomised, inter-individual dose escalation of ZK 304709 with the evaluation of safety, tolerability, pharmacokinetics, oral bioavailability and orientating efficacy after daily administration in patients with advanced cancer (7 d treatment and 14 d recovery). EUR J CANCER , 44 (15) 2162 - 2168. 10.1016/j.ejca.2008.06.006.

H

Harrison, M; Swanton, C; (2008) Epothilones and new analogues of the microtubule modulators in taxane-resistant disease. Expert Opin Investig Drugs , 17 (4) pp. 523-546. 10.1517/13543784.17.4.523.

Hazrati, A; Ramis-Castelitort, M; Sarkar, S; Barber, LJ; Schofield, CJ; Hartley, JA; McHugh, PJ; (2008) Human SNM1A suppresses the DNA repair defects of yeast pso2 mutants. DNA REPAIR , 7 (2) 230 - 238. 10.1016/j.dnarep.2007.09.013.

Howie, AJ; (2008) Handbook of renal biopsy pathology. [Book]. (2nd ed. ed.). Springer: New York, USA.

Howie, AJ; Agarwal, A; Sebire, NJ; Trompeter, RS; (2008) Glomerular tip changes in childhood minimal change nephropathy. PEDIATR NEPHROL , 23 (8) 1281 - 1286. 10.1007/s00467-008-0823-0.

K

Kanu, N; Behrens, A; (2008) ATMINistrating ATM signalling: regulation of ATM by ATMIN. Cell Cycle , 7 (22) pp. 3483-3486. 10.4161/cc.7.22.7044.

Karavasilis, V; Digue, L; Arkenau, T; Eaton, D; Stapleton, S; de Bono, J; Judson, I; (2008) Identification of factors limiting patient recruitment into phase I trials: A study from the Royal Marsden Hospital. EUROPEAN JOURNAL OF CANCER , 44 (7) pp. 978-982. 10.1016/j.ejca.2008.02.040.

L

Lee, SM; Brada, M; Stenning, S; Thompson, L; (2008) A randomised trial of Procarbazine, CCNU and Vincristine (PCV) vs Temozolomide (5-day or 21-day schedule) for recurrent high grade glioma (MRC BR12, ISRCTN83176944). In: (Proceedings) Presidential Symposium. 33rd ESMO Congress Stockholm, Sweden.

Lee, SM; James, L; Buchler, T; Snee, M; Ellis, P; Hackshaw, A; (2008) Phase II trial of thalidomide with chemotherapy and as maintenance therapy for patients with poor prognosis small-cell lung cancer. Lung Cancer , 59 (3) pp. 364-368.

Lee, SM; Rudd, RM; Woll, PJ; Ottensmeier, CH; James, LE; Gower, NH; Spiro, SG; ... Hackshaw, A; + view all (2008) Two randomised phase III, double blind, placebo controlled trials of thalidomide in patients with advanced non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). In: (Proceedings) 2008 ASCO Annual Meeting Proceedings, Chicago, IL. (pp. 435s-). Journal of Clinical Oncology

M

Marina, N; Bielack, ; S, ; Whelan, JS; Smeland, S; Krailo, M; Sydes, M; ... Bernstein, M; + view all (2008) UNSPECIFIED In: (Proceedings) International collaboration is feasible for trials in rare conditions: the EURAMOS experience. Meeting Proceedings - Paediatric and Adolescent Osteosarcoma. Progress from the past, prospects for the future.. : Houston.

Matthews, DR; Ameer-Beg, SM; Barber, P; Pierce, GP; Newman, RG; Vojnovic, B; Carlin, LM; ... Irving, M; + view all (2008) A high-content screening platform utilizing polarization anisotropy and FLIM microscopy. Progress in Biomedical Optics and Imaging - Proceedings of SPIE , 6859 10.1117/12.763310.

McTiernan, A; Morgan, R; Sydes, MR; Uscinska, B; van, GM; Bramwell, V; Souhami, RL; ... Whelan, JS; + view all (2008) The more it hurts, the better it works? Chemotherapy toxicity as a predictor of outcome from osteosarcoma: a report from the European Osteosarcoma Intergroup. In:

Meyer, T; Caplin, M; Palmer, D; Valle, JW; Larvin, M; Waters, J; Coxon, F; ... Kato, H; + view all (2008) A phase IB/IIA, multicentre, randomised, double-blind placebo controlled study to evaluate the safety and pharmacokinetics of Z-360 in subjects with unresectable advanced pancreatic cancer in combination with gemcitabine. JOURNAL OF CLINICAL ONCOLOGY , 26 (15)

Monahan, KJ; Carvajal-Carmona, L; Thirlwell, C; Thomas, HJW; Tomlinson, IP; (2008) Identification of genetic variation in dut, a potential colorectal tumour suppressor gene. In: GUT. (pp. A138 - A138). B M J PUBLISHING GROUP

N

Ng, Q.S.; (2008) Therapeutic targeting and clinical assessment of the tumour vasculature. Doctoral thesis , University of London. Green open access
file

O

Olmos, D; Arkenau, H-T; Ang, JE; de Bono, JS; Judson, I; Kaye, SB; (2008) Reply: Clinical outcome and prognostic factors for patients treated within a phase I study: the Royal Marsden Hospital Experience. BRITISH JOURNAL OF CANCER , 99 (8) p. 1365. 10.1038/sj.bjc.6604649.

P

Patkar, V; Fox, J; (2008) Clinical guidelines and care pathways: a case study applying PROforma decision support technology to the breast cancer care pathway. Stud Health Technol Inform , 139 pp. 233-242.

Patterson, DM; Murugaesu, N; Holden, L; Seckl, MJ; Rustin, GJS; (2008) A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites. Int J Gynecol Cancer , 18 (1) pp. 43-50. 10.1111/j.1525-1438.2007.00969.x.

Paulussen, M; Craft, A; Lewis, I; Hackshaw, A; Douglas, C; Dunst, J; Schuck, A; ... Jurgens, HFTEICESSG; + view all (2008) Results of the EICESS-92 study: two randomised trials of Ewing's sarcoma treatment. Journal of Clinical Oncology , 20 pp. 4385-4393.

Popat, R; Maharaj, L; Oakervee, H; Cavenagh, J; Middleton, B; Rioja, A; Marson, C; (2008) THE NOVEL HDAC INHIBITOR UCL67022 HAS POTENT ACTIVITY IN MULTIPLE MYELOMA CELLS AND REMAINS EFFECTIVE IN A BONE MARROW MICRO-ENVIRONMENT MODEL. In: (Proceedings) 13th Congress of the European-Hematology-Association. (pp. p. 115). FERRATA STORTI FOUNDATION Gold open access

Postel-Vinay, S; Arkenau, HT; Olmos, D; Barriuso, J; Ashley, S; Ang, J; De Bono, J; ... Kaye, S; + view all (2008) Patient selection criteria for PHASE-I trials in oncology: Low lymphocyte counts are associated with poor survival. In: (Proceedings) 6th International Symposium on Target Anticancer Therapies. (pp. pp. 34-35). OXFORD UNIV PRESS

R

Ray-Coquard, I; Le, CA; Whelan, JS; Scoffski, P; Bui, BN; Verweij, J; van, GM; ... Blay, J-Y; + view all (2008) A phase II study of Gefitinib for patients with HER-1 expressing advanced synovial sarcoma refractory to doxorubicin-based chemotherapy. The Oncologist , 13 pp. 467-473.

S

See, TC; Thompson, BC; Howie, AJ; Karamshi, M; Papadopoulou, AM; Davies, N; Tibballs, J; (2008) Transjugular renal biopsy: Our experience and technical considerations. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY , 31 (5) pp. 906-918. 10.1007/s00270-008-9308-6.

Shah, T; Kulakiene, I; Quigley, AM; Warbey, VS; Srirajaskanthan, R; Toumpanakis, C; Hochhauser, D; ... Caplin, ME; + view all (2008) The role of <sup>99m</sup>Tc-depreotide in the management of neuroendocrine tumours. Nuclear Medicine Communications , 29 (5) pp. 436-440.

Shah, T; Kulakiene, I; Quigley, AM; Warbey, VS; Srirajaskanthan, R; Tournpanakis, C; Hochhauser, D; ... Caplin, ME; + view all (2008) The role of Tc-99m-depreotide in the management of neuroendocrine tumours. NUCLEAR MEDICINE COMMUNICATIONS , 29 (5) 436 - 440.

Short, S; C, ; (2008) Survival from brain tumours in England and Wales up to 2001. British Journal of Cancer

Siddika, A; Jamal-Hanjani, M; Coker, JB; Ullah, MZ; (2008) Laparoscopy: a tool for the diagnosis and treatment of omental torsion. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , 62 (11) pp. 1807-1808. 10.1111/j.1742-1241.2006.00900.x.

Sky, NO; (2008) EMEA Likely To Give Go Ahead On Thalidomide. UNSPECIFIED

Speetjens, FM; de Bruin, EC; Morreau, H; Zeestraten, ECM; Putter, H; van Krieken, JH; van Buren, MM; ... Kuppen, PJK; + view all (2008) Clinical impact of HLA class I expression in rectal cancer. Cancer Immunol Immunother , 57 (5) pp. 601-609. 10.1007/s00262-007-0396-y.

Spratlin, J; Arkenau, HT; George, S; Serkova, NJ; Germuska, M; Brock, K; Gedrich, R; ... Camidge, DR; + view all (2008) Analyses of pharmacodynamic (PD) assessments collected during expanded cohorts (EC) of a phase I trial with OSI-930, a multi-targeted oral tyrosine kinase inhibitor (TKI). In: (Proceedings) 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics. (pp. p. 19). PERGAMON-ELSEVIER SCIENCE LTD

Srirajaskanthan, R; Marelli, L; Mendes, N; Krepska, A; Davidson, A; Toumpanakis, C; Meyer, T; ... Caplin, M; + view all (2008) Diagnosis, management and survival of pancreatic endocrine tumours. In: (Proceedings) Annual General Meeting of the British-Society-of-Gastroenterology. (pp. A161-A161). B M J PUBLISHING GROUP

T

Taylor, RE; Pizer, BL; Short, S; (2008) Promoting collaboration between adult and paediatric clinical trial groups. Clin Oncol (R Coll Radiol) , 20 (9) pp. 714-716. 10.1016/j.clon.2008.06.009.

Thirlwell, C; Nathan, P; (2008) Melanoma - Part 2: management. BRIT MED J , 337 , Article a2488. 10.1136/bmj.a2488.

V

Vassileva, V; Piquette-Miller, M; (2008) Ovarian tumour repopulation in response to sustained and intermittent paclitaxel therapy. In: (Proceedings) 109th Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics. (pp. S52-S52). NATURE PUBLISHING GROUP

Vassileva, VT; (2008) The Effects of Sustained and Intermittent Intraperitoneal Paclitaxel Chemotherapy on Tumour Repopulation and Response in Ovarian Cancer. Doctoral thesis , University of Toronto.

W

Wang, M-L; Panasyuk, G; Gwalter, J; Nemazanyy, I; Fenton, T; Filonenko, V; Gout, I; (2008) Regulation of ribosomal protein S6 kinases by ubiquitination. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS , 369 (2) pp. 382-387. 10.1016/j.bbrc.2008.02.032.

Whelan, J; Fern, L; (2008) Keynote Comment: Poor rates of accrual of teenagers and young adults into clinical trials in the UK. The Lancet Oncology , 9 pp. 306-307.

Whelan, J; Fern, LA; (2008) Rates of inclusion of teenagers and young adults (TYA) with cancer into UK National Cancer Research Institute (NCRI) clinical trials, 2005-2007. In: AMER SOC CLINICAL ONCOLOGY

Whelan, J; Sydes, M; Bielack, S; Sigbjorn, S; Marina, N; May, B; Butterfass-Bahloul, T; ... Bernstein, M; + view all (2008) Successful trans-Atlantic collaboration in a randomised controlled trial in osteosarcoma:EURAMOS1 (ISRCTN67613327; a trial conducted as part of ECT EUROCORES) - a potential model for collaboration in rare diseases. In:

Whelan, JS; McTiernan, A; Morgan, R; Sydes, MR; Souhami, RL; Bramwell, V; Lewis, I; ... Taminiau, A; + view all (2008) Mature results of 1067 patients treated in three European Osteosarcoma Intergroup randomised studies. In:

Wilson, RH; Plummer, R; Adam, J; Eatock, MM; Boddy, AV; Griffin, M; Miller, R; ... Calvert, H; + view all (2008) Phase I and pharmacokinetic study of NC-6004, a new platinum entity of cisplatin-conjugated polymer forming micelles. In: AMER SOC CLINICAL ONCOLOGY

This list was generated on Sun May 20 01:52:28 2018 BST.